Clinical Trial Update: Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating the combination of venetoclax and dexamethasone for relapsed or refractory AL amyloidosis with t(11;14) translocation, currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Al Amyloidosis

Drugs mentioned

• Decadron (Dexamethasone)
• Venetoclax (venetoclax)

Snippet

Sponsor: Rajshekhar Chakraborty, MD | Conditions: AL Amyloidosis | Phase 1, Phase 2 | Status: RECRUITING